AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 40 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,960,000 | -2.1% | 12,000,000 | 0.0% | 5.10% | +32.2% |
| Q2 2023 | $28,560,000 | +55.2% | 12,000,000 | +20.0% | 3.86% | +56.6% |
| Q1 2023 | $18,400,000 | +16.7% | 10,000,000 | +20.5% | 2.46% | +9.1% |
| Q4 2022 | $15,770,000 | +142.5% | 8,300,000 | +173.1% | 2.26% | +187.8% |
| Q3 2022 | $6,504,000 | -23.9% | 3,039,381 | +0.7% | 0.78% | +34.0% |
| Q2 2022 | $8,545,000 | -27.5% | 3,019,413 | +6.8% | 0.58% | +9.6% |
| Q1 2022 | $11,784,000 | -15.9% | 2,825,937 | +4.7% | 0.53% | -36.8% |
| Q4 2021 | $14,013,000 | -14.4% | 2,700,000 | +8.0% | 0.84% | -15.8% |
| Q3 2021 | $16,375,000 | -1.4% | 2,500,000 | 0.0% | 1.00% | +10.9% |
| Q2 2021 | $16,600,000 | +18.9% | 2,500,000 | +2.6% | 0.90% | -9.3% |
| Q1 2021 | $13,957,000 | -27.4% | 2,435,714 | +13.3% | 1.00% | -22.5% |
| Q4 2020 | $19,221,000 | -23.2% | 2,150,000 | 0.0% | 1.29% | -44.0% |
| Q3 2020 | $25,026,000 | -27.4% | 2,150,000 | 0.0% | 2.30% | -49.9% |
| Q2 2020 | $34,465,000 | +190.2% | 2,150,000 | +8.4% | 4.59% | +123.3% |
| Q1 2020 | $11,876,000 | -30.8% | 1,982,601 | +52.5% | 2.06% | -19.4% |
| Q4 2019 | $17,160,000 | +6.3% | 1,300,000 | 0.0% | 2.55% | -11.4% |
| Q3 2019 | $16,146,000 | +0.3% | 1,300,000 | +30.0% | 2.88% | +23.2% |
| Q2 2019 | $16,100,000 | -39.9% | 1,000,000 | +17.4% | 2.34% | -29.9% |
| Q1 2019 | $26,801,000 | +2.0% | 851,631 | +6.5% | 3.33% | -19.6% |
| Q4 2018 | $26,272,000 | +8.4% | 800,000 | +1.2% | 4.14% | +42.9% |
| Q3 2018 | $24,234,000 | +3517.0% | 790,150 | +3060.6% | 2.90% | +3052.2% |
| Q2 2018 | $670,000 | – | 25,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |